Prockop, S., Doubrovina, E., Suser, S., Heller, G., Barker, J., Dahi, P., . . . O’Reilly, R. J. (2020). Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation. J Clin Invest.
Citação norma ChicagoProckop, Susan, et al. "Off-the-shelf EBV-specific T Cell Immunotherapy for Rituximab-refractory EBV-associated Lymphoma Following Transplantation." J Clin Invest 2020.
Citação norma MLAProckop, Susan, et al. "Off-the-shelf EBV-specific T Cell Immunotherapy for Rituximab-refractory EBV-associated Lymphoma Following Transplantation." J Clin Invest 2020.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.